article thumbnail

Can you work while in Medical School? The Physician Pharmacist Do's and Don'ts

The Physician Pharmacist

Whether you've finished the medical school application cycle or are just curious about the economics of medical school, the answer to our question is obviously yes ! You undoubtedly worked as a pharmacy intern during school, so I am confident that you can easily work as a higher paying pharmacist.

article thumbnail

Opinion: Listen: Covid is not a ‘racial equity success story’

STAT

Chomilo, a pediatrician and internist at the University of Minnesota Medical School. To be sure, it’s worth celebrating the tenacity of community champions who relentlessly fought for equitable access to vaccines and the subsequent reduction in deaths among Black and Hispanic people. Not so fast, says Nathan T.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First nasal monoclonal antibody COVID-19 treatment shows potential

European Pharmaceutical Review

“We discovered a way to shut down inflammation… in a patient with multiple sclerosis as well as in healthy patients,” stated lead author Thais Moreira, PhD, an assistant scientist at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital and an instructor in Neurology at Harvard Medical School.

article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

article thumbnail

STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug

STAT

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.

article thumbnail

Coordinating and delivering research in the pandemic: The UK approach

pharmaphorum

More recently Kirsty has overseen the clinical trial work for COVID-19 and provided regulatory expertise on vaccines both within MHRA but also as part of the government Vaccine Taskforce. Professor Nick Lemoine is medical director of the National Institute for Health Research Clinical Research Network for England.